Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Inv. presentation
Quarterly results

IDEAYA Biosciences, Inc. (IDYA) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/24/2023 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 5.1% stake in IDEAYA Biosciences, Inc.
02/27/2023 SC 13G ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.4% stake in IDEAYA Biosciences, Inc.
10/27/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/02/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/18/2022 SC 13G Logos Global Management LP reports a 6.9% stake in IDEAYA Biosciences, Inc.
02/18/2022 SC 13G Point72 Asset Management, L.P. reports a 5.3% stake in IDEAYA Biosciences, Inc.
02/14/2022 SC 13G PRICE T ROWE ASSOCIATES INC reports a 7% stake in IDEAYA Biosciences, Inc.
02/14/2022 SC 13G FEDERATED HERMES, INC. reports a 6% stake in IDEAYA BIOSCIENCES, INC.
02/04/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/01/2021 SC 13G Avidity Partners Management LP reports a 6.4% stake in IDEAYA Biosciences, Inc.
01/22/2021 SC 13G RTW INVESTMENTS, LP reports a 7.2% stake in IDEAYA Biosciences, Inc.
06/29/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/23/2020 SC 13G WuXi Healthcare Ventures II, L.P. reports a 6.9% stake in IDEAYA Biosciences, Inc.
02/13/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/06/2020 SC 13G CANAAN X L.P. reports a 13.1% stake in IDEAYA Biosciences, Inc.
06/07/2019 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 7.4% stake in IDEAYA Bioscience, Inc.
05/30/2019 SC 13G CELGENE CORP reports a 8.4% stake in IDEAYA Biosciences, Inc.
05/29/2019 SC 13G PERCEPTIVE ADVISORS LLC reports a 6.9% stake in IDEAYA Biosciences, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy